United Airlines Holdings is opening a new 14-gate concourse at Washington Dulles International Airport, positioning the carrier to boost flights at one of its key hubs as the airport embarks on a more than $20 billion overhaul.

United States Attorney for the Southern District of Florida Jason Reding Quiñones submitted his resignation from the Department of Justice. We are grateful for Jason’s leadership in combatting violent crime, drug trafficking, sex trafficking, and transnational crime, including the indictment of Raúl Castro. Jason has served the Department multiple times over his distinguished career, and we thank him for his service to this country.

United Parks ($PRKS) Q3 attendance fell 4.7%, while revenue and EPS both missed estimates. Still, 2027 pass sales are up more than 15% and forward bookings are running double digits higher, with CEO Marc Swanson expecting “significantly higher” growth next year.

UNITED THERAPEUTICS $UTHR Q3’26 EARNINGS HIGHLIGHTS 🔹 Revenue: $832.5M (Est. $781M) 🟢; +4% YoY 🔹 EPS: $5.71 (Est. $6.42) 🔴; -20% YoY 🔹 Operating Income: $307.8M (Est. $347M) 🔴 Revenue Breakdown: 🔹 Tyvaso DPI: $378.5M; +13% YoY 🔹 Nebulized Tyvaso: $125.3M; -12% YoY 🔹 Orenitram: $145.0M; +11% YoY 🔹 Remodulin: $122.0M; -3% YoY 🔹 Adcirca: $4.5M; -54% YoY Announcements: 🔹 Share Repurchase: Up to $2.0B authorized through October 21, 2027 Key Updates: 🔹 Other R&D: $130.0M, primarily tied to Thymmune acquisition IPR&D Comments: 🔸 “United Therapeutics is entering a period of extraordinary growth. We are advancing a portfolio of new therapies designed to exponentially increase the number of patients we can serve.” 🔸 “Our strategies are delivering, securing an increasingly strong position to leverage our commercial operations. With a durable and robust foundation combined with significant new opportunities across cardiopulmonary and respiratory medicine rapidly approaching, we believe we have the strongest growth outlook in our history.”